Immunic Inc

IMUXNASDAQ · USD
10.84USD0.00 (+0.10%)
159

Immunic Inc (IMUX) Implied Volatility Current

IMUX implied volatility is 75%. IV Rank is 1%, placing current premiums in the bottom of their 52-week range.

Read more

Tracking IMUX implied volatility helps you identify when options premiums on Immunic Inc are historically cheap or expensive, and where the best trades are hiding. Immunic Inc implied volatility reflects the market's expectation of future price movement: when IMUX IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Immunic Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For IMUX, tracking metrics like IMUX IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on IMUX signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and other chronic inflammatory and autoimmune diseases, as well as to treat coronavirus disease. The company is also developing IMU-935, an inverse agonist of ROR?t; and IMU-856 for the restoration of the intestinal barrier function in patients suffering from diseases, such as inflammatory bowel disease, irritable bowel syndrome with diarrhea, immune checkpoint inhibitor induced colitis, and other intestinal barrier function diseases.

Immunic, Inc. is headquartered in New York, New York.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where IMUX implied volatility sits today versus where it has been. Our scanner ranks Immunic Inc implied volatility against its historical range, surfaces extremes in IMUX IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Immunic Inc IV is rich or cheap — measure it, then act on it.

Implied Volatility

IV Rank
0.79%IV Rank
Low

IV is compressed vs the past year - options are relatively cheap, favoring buyers.

Implied Volatility (30d)75.11%

IV Rank0.79%

Historical Volatility (30d)67.20%

IV - HV+7.91%

As of September 22, 2026

Trade options with IV on your side

Track IMUX IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.

Start your 14-day free trial